Secretome hypoxia-mesenchymal stem cells decrease tumor necrosis factor-α and interleukin-18 in kidney of type 2 diabetes mellitus model rats
ackground Type 2 diabetes mellitus (T2DM) is a chronic disease that affects millions of people worldwide and associated with an increased risk of kidney damage caused by prolonged inflammation. Secretome hypoxia- mesenchymal stem cells (SH-MSCs) have been investigated as a potential therapy for kid...
Main Authors: | Risky Chandra Satria Irawan, Agung Putra, Trisnadi Setyo, Shabrina Syifa Ghaisani, Nurul Hidayah |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine Trisakti University
2023-12-01
|
Series: | Universa Medicina |
Subjects: | |
Online Access: | https://univmed.org/ejurnal/index.php/medicina/article/view/1473 |
Similar Items
-
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome
by: Suya Wang, et al.
Published: (2022-03-01) -
Study of serum bisphenol-A and the mRNA of galactosidase beta 1 and tumor necrosis factor alpha in Egyptian patients with type 2 diabetes mellitus
by: Yasmin Ibrahim Zanet, et al.
Published: (2023-03-01) -
Secretome Analysis of Rabbit and Human Mesenchymal Stem and Endothelial Progenitor Cells: A Comparative Study
by: Jaromír Vašíček, et al.
Published: (2021-11-01) -
Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
by: Hideki Kitaura, et al.
Published: (2022-01-01)